Dr. He is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-6786Fax+1 614-293-1470
Education & Training
- Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2012 - 2015
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2009 - 2012
- Peking Union Medical CollegeClass of 1996
Certifications & Licensure
- OH State Medical License 2016 - 2026
- MD State Medical License 2013 - 2016
Clinical Trials
- A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors Start of enrollment: 2020 Aug 17
Roles: Principal Investigator
Publications & Presentations
PubMed
- 49 citationsAdvances in epigenetic therapeutics with focus on solid tumors.Ning Jin, Tiffany L. George, Gregory A. Otterson, Claire F. Verschraegen, Haitao Wen
Clinical Epigenetics. 2021-04-20 - 67 citationsMetalloprotease-mediated GH Receptor Proteolysis and GHBP Shedding DETERMINATION OF EXTRACELLULAR DOMAIN STEM REGION CLEAVAGE SITEXiangdong Wang, Kai He, Mary Gerhart, Yao Huang, Jing Jiang
The Journal of Biological Chemistry. 2002-12-27 - 16 citationsReduced proteolysis of rabbit growth hormone (GH) receptor substituted with mouse GH receptor cleavage site.Xiangdong Wang, Kai He, Mary Gerhart, Jing Jiang, Raymond J. Paxton
Molecular Endocrinology. 2003-10-01
Journal Articles
- Identifying Patterns of Care for Elderly Patients with Non-Surgically Treated Stage III Non-Small Cell Lung Cancer: An Analysis of the National Cancer DatabaseKai He, Terence M Williams, John C Grecula, Eric D Miller, Erin M Bertino, David P Carbone, Peter G Shields, Jose G Bazan, Karl E Haglund, Gregory A Otterson, BioMed Central
- Rapid and Highly Sensitive Detection of Therapeutically Relevant Oncogenic Driver Mutations in EBUS-TBNA Specimens from Patients with Lung AdenocarcinomaKai He, MD, Clinical Lung Cancer
Press Mentions
- Could a Dissolving Implant Revolutionize How We Manage Pain?July 8th, 2022
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: